All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Why assessing t(11;14) can be the first step towards personalized therapy in MM?

During the Lymphoma, Leukemia & Myeloma 2021 Virtual Congress, the MM hub was pleased to speak to Rafael Fonseca, Mayo Clinic, Phoenix, US. We asked, Why assessing t(11;14) can be the first step towards personalized therapy in MM?

Why assessing t(11;14) can be the first step towards personalized therapy in MM?

In this video, Fonseca discusses the translocation (11;14) and its impact in personalized therapy for patients with multiple myeloma.

 

Share: